Phathom Pharmaceuticals Inc

Research Phathom Pharmaceuticals Inc (PHAT) on Bullrun: market cap USD 866.95M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerPHAT
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 866.95M
• Financial periodFY2025
• RevenueUSD 175.11M
• Revenue growth216.9%
• Net income-USD 221.25K
• Free cash flow-USD 167.00M
• Gross margin87.1%

Valuation Snapshot

latest market cap is USD 866.95M.

About Phathom Pharmaceuticals Inc

Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases in the United States. It develops VOQUEZNA, which has completed Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease (GERD) and related heartburn in adults;

Frequently asked questions

What is Phathom Pharmaceuticals Inc's market cap?

Phathom Pharmaceuticals Inc's market capitalization is USD 866.95M.

What does Phathom Pharmaceuticals Inc do?

Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases in the United States.